Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 54.8%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 32,900 shares, a drop of 54.8% from the February 28th total of 72,800 shares. Based on an average daily trading volume, of 127,900 shares, the short-interest ratio is presently 0.3 days. Approximately 0.2% of the company’s shares are short sold.

China SXT Pharmaceuticals Trading Up 2.2 %

Shares of SXTC opened at $2.78 on Friday. The company has a 50-day moving average of $3.42 and a 200 day moving average of $3.85. China SXT Pharmaceuticals has a 1-year low of $2.40 and a 1-year high of $26.96.

About China SXT Pharmaceuticals

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Further Reading

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.